Click
here for printer-friendly version
- Medical enrollment grew to 34.2 million members as of March 31, 2006
- Net income was $1.09 per share, exceeding expectations by $0.02
per share
- Full year 2006 earnings guidance raised to $4.63 per share, including
net realized investment losses of $0.01 per share
- Operating cash flow totaled $1.8 billion in the quarter, or 2.5 times
net income
- During the first quarter, the Company repurchased 24.7 million shares of
its common stock for $1.9 billion
INDIANAPOLIS, April 26 /PRNewswire-FirstCall/ -- WellPoint, Inc.
(NYSE: WLP) today announced that first quarter 2006 net income was $731.8
million, or $1.09 per share, including costs of $0.04 per share for the impact
of expensing stock options in accordance with FAS 123R and net realized
investment losses of $0.01 per share. Net income for the first quarter of
2005 was $611.7 million, or $0.98 per share, which included tax benefits of
approximately $0.04 per share due to the favorable resolution of a tax matter
relating to the sale of certain subsidiaries in the mid-1990s.
"Our first quarter results build upon the exceptional performance we
achieved last year and establish a strong foundation for yet another
successful year of growth going forward," said Larry C. Glasscock, chairman,
president and chief executive officer of WellPoint, Inc. "WellPoint today is
delivering more value to our members than ever before while helping to hold
down the rising costs of health care. Our continued membership growth
indicates that we are delivering the products and services consumers are
looking for today."
"During the first quarter, we were very successful in executing on our
Board approved share repurchase program. As of March 31, 2006, we repurchased
24.7 million shares of common stock for a total cost of $1.9 billion," said
David C. Colby, executive vice president and chief financial officer of
WellPoint, Inc. "In addition, as a result of our strong earnings and cash
flow, the Board of Directors increased our share buy-back authorization by an
additional $1.0 billion in March 2006. We expect to complete this repurchase
during the second quarter."
COMPARABLE BASIS INFORMATION
On December 28, 2005, WellPoint, Inc. acquired WellChoice, Inc. For
accounting purposes, the transaction was assumed to have closed on
December 31, 2005. Accordingly, operations of the former WellChoice, Inc. are
included in reported financial results for the first quarter of 2006.
However, operations of the former WellChoice, Inc. are not included in
reported financial results for the first quarter of 2005.
Unless otherwise indicated, the analysis in this press release compares
reported financial results and does not adjust results for the effects of this
acquisition. In certain areas, we have included "comparable basis" analyses
that we believe provide more meaningful comparisons between periods, due to
the inclusion of operations of the former WellChoice, Inc. in the comparable
historical results. The "comparable basis" information is not calculated in
accordance with U.S. generally accepted accounting principles ("GAAP") and is
not intended to represent or be indicative of the results that WellPoint, Inc.
would have reported had the acquisition been completed as of the dates
presented, and should not be taken as representative or indicative of our
future results. The methodologies for calculating the comparable basis
information are either described within the text of the press release, or in
the tables at the end of the press release where such comparable basis
information is reconciled to WellPoint, Inc.'s reported GAAP financial
results.
CONSOLIDATED HIGHLIGHTS
Membership: Medical enrollment totaled 34.2 million members at March 31,
2006, an increase of more than 5.6 million members from 28.5 million at
March 31, 2005, including approximately 4.8 million members acquired through
the WellChoice transaction.
On a comparable basis, enrollment increased by 947,000 members since
March 31, 2005. The increase was driven by gains of more than 900,000 members
in the National business and growth of 140,000 members in State Sponsored
operations. Growth was also realized in the Individual and Small Group
("ISG") and Senior businesses, while Large Group enrollment declined due
primarily to the previously-announced loss of the 315,000 member state of
Georgia PPO account.
Medical enrollment grew by 302,000 members during the first quarter of
2006. An increase of more than 640,000 members in the National business was
partially offset by a decrease in Large Group enrollment that resulted
primarily from the loss of the Georgia state members and movement of other
accounts to the National business classification due to group size growth. In
addition to the growth in medical enrollment, the Company added 1.3 million
new Medicare Part D members during the quarter.
Self-funded membership represented approximately 50 percent of medical
enrollment at March 31, 2006, an increase from approximately 48 percent of
comparable medical enrollment at March 31, 2005, and approximately 49 percent
at December 31, 2005.
Enrollment data for 2005 has been reclassified to conform to the current
presentation of membership related to minimum premium amendments to fully-
insured contracts. This reclassification resulted in a 350,000 member
increase in self-funded enrollment at December 31, 2005, and a corresponding
decrease in fully-insured enrollment, with no impact on total enrollment from
that which was previously reported. Similar financial statement
reclassifications have been made, as further described below in "Basis of
Presentation" and in the tables at the end of this press release.
Operating Revenue: Operating revenue was $13.6 billion in the first
quarter 2006, an increase of 26.0 percent from $10.8 billion in the prior year
quarter.
On a comparable basis, first quarter 2006 operating revenue increased by
$1.3 billion, or 10.4 percent, versus $12.3 billion in the prior year period.
The increase resulted primarily from disciplined pricing across all business
lines, the addition of the New York state prescription drug contract and new
enrollment in the Company's Medicare Part D products.
Benefit Expense Ratio: The benefit expense ratio was 81.3 percent in the
first quarter of 2006, a 40 basis point increase compared with 80.9 percent in
the first quarter of 2005.
On a comparable basis, the first quarter 2006 benefit expense ratio
declined by 20 basis points, compared with 81.5 percent in the first quarter
of 2005. The decrease was consistent with the Company's prior guidance and
reflected moderating medical cost trend, operating improvements in WellChoice
entities as well as the year-over-year mix of business changes.
Premium and Cost Trends: Trends include Large Group and ISG fully-insured
businesses.
For the rolling 12-month period ended March 31, 2006, the primary drivers
of medical trend were inpatient and outpatient costs. Commercial premium
yield for the same period exceeded total cost trend, where total cost trend
included medical costs and selling, general and administrative ("SG&A")
expense, resulting in an increase in underwriting margin.
Based on medical trends in the first quarter 2006, the Company remains
comfortable with its 2006 medical cost trend estimate of less than 8.0
percent, or 50 basis points lower than the 2005 trend.
SG&A Expense Ratio: The SG&A expense ratio was 16.0 percent in the first
quarter of 2006, equal to the ratio in the first quarter of 2005.
On a comparable basis, the first quarter 2005 ratio was also 16.0 percent.
The ratio remained flat year-over-year primarily due to the continued
leveraging of administrative costs over a growing revenue base, including
efficiencies obtained through integration initiatives. These improvements
offset the impact of the shift in business mix towards more self-funded
medical enrollment, which increased the current quarter ratio by approximately
40 basis points over the past year. The current year also included increased
costs for stock option expensing, which added 30 basis points to the ratio.
Operating Cash Flow: First quarter 2006 operating cash flow was $1.8
billion, or 2.5 times net income. The results included the receipt of $447.6
million in CMS payments that relate to the second quarter of 2006. Excluding
these CMS payments, the first quarter operating cash flow was 1.8 times net
income.
Days in Claims Payable: In order to provide a more meaningful comparison
between periods, days in claims payable as of December 31, 2005, has been
presented on a comparable basis, as illustrated in the tables at the end of
this press release.
Days in claims payable as of March 31, 2006, was 45.4 days, a decrease of
1.6 days from 47.0 days (adjusted to include WellChoice for the entire fourth
quarter 2005) as of December 31, 2005. This decrease resulted primarily from
the addition of the New York state prescription drug contract and the new
Medicare Part D program during the first quarter. Since pharmaceutical claims
are processed more quickly than medical claims, these new programs reduced the
Company's average time to pay a claim.
Share Repurchase Program: During the first quarter 2006, the Company
repurchased 24.7 million shares of its common stock for $1.9 billion. The
Board of Directors increased the 2006 share repurchase authorization by an
additional $1.0 billion on March 15, 2006. Based on the current stock price
and the strong financial results in the first quarter, the Company intends to
utilize the remaining authorization during the second quarter of 2006, subject
to market conditions.
REPORTABLE SEGMENTS
WellPoint, Inc. has three reportable segments: Health Care, Specialty and
Other. Operating revenue and operating gain are the key measures used by
management to evaluate performance in each segment.
WellPoint, Inc.
Reportable Segment Highlights
(Unaudited)
Three Months Ended
($ In Millions) March 31,
2006 2005 Change
Operating Revenue
Health Care $13,057.9 $10,283.1 27.0%
Specialty 854.2 750.9 13.8%
Other:
External Customers 116.4 88.1 32.1%
Intercompany Eliminations (413.8) (316.7) (30.7%)
Total Other (297.4) (228.6) (30.1%)
Total Operating Revenue 13,614.7 10,805.4 26.0%
Operating Gain (Loss)
Health Care $1,035.9 $856.7 20.9%
Specialty 113.6 94.4 20.3%
Other (14.0) (47.5) 70.5%
Health Care: Operating gain for the Health Care segment exceeded $1.0
billion in the first quarter of 2006, an increase of 20.9 percent, compared
with $856.7 million in the first quarter of 2005.
On a comparable basis, first quarter 2006 operating gain increased by
$82.2 million, or 8.6 percent, compared with $953.7 million in the prior year
quarter. The improvement resulted from disciplined pricing in each of the
businesses and strong overhead expense control that offset additional costs
incurred during the current quarter for stock option expensing and Medicare
Part D implementation.
Specialty: Operating gain totaled $113.6 million in the first quarter of
2006, an increase of 20.3 percent compared with $94.4 million in the first
quarter of 2005.
First quarter 2006 operating gain increased by $18.6 million, or 19.6
percent on a comparable basis, from $95.0 million in the prior year quarter.
The increase resulted primarily from increased prescription volume and
improved contracting at the Company's pharmacy benefit management ("PBM")
operation. Prescription volume reached almost 110 million scripts during the
first quarter 2006, a year-over-year increase of more than 26 million scripts,
or 31.2 percent, due primarily to the impact of Medicare Part D.
Other: The operating loss in the Other segment totaled $14.0 million in
the first quarter of 2006, compared with a loss of $47.5 million in the first
quarter of 2005.
On a comparable basis, the operating loss in this segment declined by
$35.2 million from $49.2 million in the prior year period due primarily to
lower compensation expenses related to merger activities and allocations.
OUTLOOK
Full Year 2006:
- The Company now expects net income of $4.63 per share, including net
realized investment losses of $0.01 per share. This estimate assumes the
Company completes its remaining share repurchase authorization during the
second quarter of 2006.
- Operating revenue is now expected to total approximately $56.6 billion.
- The benefit expense ratio is now expected to be approximately 80.9
percent.
- The SG&A expense ratio is now expected to be approximately 16.0 percent.
- Operating cash flow is expected to exceed $4.0 billion.
- Year-end medical enrollment is expected to be approximately 34.8 million
members, consistent with previously expected growth that is closer to the low
end of the Company's targeted range of 3 percent to 5 percent per year, due
primarily to the loss of the state of Georgia PPO account.
Second Quarter 2006:
- The Company now expects net income of $1.14 per share in the second
quarter.
Basis of Presentation
1. Operating gain is defined as operating revenue less benefit expense,
selling expense, general and administrative expense, and cost of drugs.
Operating gain is used to analyze profit or loss on a segment basis.
Consolidated operating gain is a non-GAAP measure.
2. All income per share amounts are on an after-tax, diluted per share
basis and reflect the two-for-one stock split on May 31, 2005.
3. On December 28, 2005, WellPoint, Inc. acquired WellChoice, Inc.
Accordingly, operations of the former WellChoice, Inc. are included in
reported financial results for the first quarter of 2006. However, operations
of the former WellChoice, Inc. are not included in reported financial results
for the first quarter of 2005.
4. Amounts for 2005 and prior do not include the impact of expensing
stock options in accordance with FAS 123R. The Company's first quarter 2006
reported results and its outlook for the remainder of 2006, however, do
include stock option expense.
5. Certain prior period amounts have been reclassified to conform to
current period presentation. In connection with the acquisition of
WellChoice, Inc., the Company adopted a consistent practice for reporting
minimum premium amendments to fully-insured contracts throughout the combined
enterprise. As a result, consistency reclassifications have been made among
certain prior period financial statement line items; however these
reclassifications did not change net income or net income per diluted share.
Conference Call and Webcast
Management will host a conference call and webcast today at 8:30 a.m.
Eastern Daylight Time ("EDT") to discuss its first quarter earnings results
and updated outlook. The conference call should be accessed at least 15
minutes prior to the start of the call with the following numbers:
888-423-3268 (Domestic) 800-475-6701 (Domestic Replay)
651-291-5254 (International) 320-365-3844 (International Replay)
An access code is not required for today's conference call. The access
code for the replay is 822441. The replay will be available from 1:45 p.m.
EDT today until the end of the day on May 10, 2006. The call will also be
available through a live webcast at http://www.wellpoint.com under "Investor
Info." A webcast replay will be available following the call.
About WellPoint, Inc.
WellPoint's mission is to improve the lives of the people it serves and
the health of its communities. WellPoint, Inc. is the largest health benefits
company in terms of commercial membership in the United States. Through its
nationwide networks, the company delivers a number of leading health benefit
solutions through a broad portfolio of integrated health care plans and
related services, along with a wide range of specialty products such as life
and disability insurance benefits, pharmacy benefit management, dental,
vision, behavioral health benefit services, as well as long term care
insurance and flexible spending accounts. Headquartered in Indianapolis,
Indiana, WellPoint is an independent licensee of the Blue Cross and Blue
Shield Association and serves its members as the Blue Cross licensee for
California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut,
Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the
Kansas City area), Nevada, New Hampshire, New York (as Blue Cross Blue Shield
in 10 New York City metropolitan and surrounding counties and as Blue Cross or
Blue Cross Blue Shield in selected upstate counties only), Ohio, Virginia
(excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and
through UniCare. Additional information about WellPoint is available at
http://www.wellpoint.com .
WellPoint, Inc.
Medical Membership & Specialty Metrics Summary
(Unaudited and in Thousands)
Medical Membership
Comparable
As Reported Basis (1)
March 31, March 31, March 31, December 31,
2006 2005 2005 2005
Customer Type
Large Group 15,982 13,146 16,173 16,362
Individual and Small
Group (ISG) 5,648 5,254 5,581 5,645
National Accounts 5,162 3,465 4,707 4,776
BlueCard 4,171 3,845 3,721 3,915
Total National 9,333 7,310 8,428 8,691
Senior 1,237 1,059 1,211 1,224
State Sponsored 1,958 1,752 1,818 1,934
Total 34,158 28,521 33,211 33,856
Funding Arrangement
Self-Funded (2) 16,997 14,124 15,926 16,584
Fully-Insured (2) 17,161 14,397 17,285 17,272
Total 34,158 28,521 33,211 33,856
Regional Membership
East 13,805 8,758 13,693 13,800
Central 11,038 10,755 10,629 10,970
West 9,315 9,008 8,889 9,086
Total 34,158 28,521 33,211 33,856
Specialty Metrics
PBM Prescription
Volume (3) 109,756 83,669 83,669 91,813
Behavioral Health
Membership 16,065 12,280 12,280 15,669
Life and Disability
Membership 5,920 6,081 6,081 5,826
Dental Membership 5,256 5,267 5,525 5,195
Medicare Part D
Membership (4) 1,299 -
- - -
- -
Vision Membership 907 785 785 816
Change from
Comparable
Basis (1)
March 31, December 31,
2005 2005
Customer Type
Large Group (1.2%) (2.3%)
Individual and Small
Group (ISG) 1.2% 0.1%
National Accounts 9.7% 8.1%
BlueCard 12.1% 6.5%
Total National 10.7% 7.4%
Senior 2.1% 1.1%
State Sponsored 7.7% 1.2%
Total 2.9% 0.9%
Funding Arrangement
Self-Funded (2) 6.7% 2.5%
Fully-Insured (2) (0.7%) (0.6%)
Total 2.9% 0.9%
Regional Membership
East 0.8% 0.0%
Central 3.8% 0.6%
West 4.8% 2.5%
Total 2.9% 0.9%
Specialty Metrics
PBM Prescription Volume (3) 31.2% 19.5%
Behavioral Health Membership 30.8% 2.5%
Life and Disability Membership (2.6%) 1.6%
Dental Membership (4.9%) 1.2%
Medicare Part D Membership (4) -
- -
-
Vision Membership 15.5% 11.2%
(1) "Comparable Basis" data was calculated by adding historical data for
the former WellChoice, Inc. to WellPoint, Inc.'s historical data, and
adjusting the combined totals to ensure a consistent approach for counting
membership (see footnote 2 below) and to eliminate overlapping BlueCard host
membership.
(2) Membership data as of March 31, 2005, and December 31, 2005, has been
reclassified to conform to current period presentation. The Company's
reclassifications for minimum premium amendments to fully-insured contracts
resulted in an increase in self-funded membership and a corresponding decrease
in fully-insured membership, with no impact on total membership at either date
presented.
(3) Represents quarterly prescription volume at the Company's PBM
operation.
(4) Includes auto-assigned, stand-alone, Medicare Advantage, group waiver
and external PBM members with the prescription drug plan benefit.
WellPoint, Inc.
Consolidated Statements of Income
(Unaudited)
($ In Millions, Except Per Share Data) Three Months Ended
March 31
2006 2005 Change
Revenues
Premiums $12,578.9 $10,015.9 25.6%
Administrative fees 884.0 660.7 33.8%
Other revenue 151.8 128.8 17.9%
Total operating revenue 13,614.7 10,805.4 26.0%
Net investment income 212.1 138.7 52.9%
Net realized losses on investments (7.1) (1.0) (610.0%)
Total revenues 13,819.7 10,943.1 26.3%
Expenses
Benefit expense 10,230.8 8,099.1 26.3%
Selling, general and
administrative expense
Selling expense 401.4 359.5 11.7%
General and administrative expense 1,771.2 1,369.6 29.3%
Total selling, general and
administrative expense 2,172.6 1,729.1 25.6%
Cost of drugs 75.8 73.6 3.0%
Interest expense 94.0 53.2 76.7%
Amortization of other intangible
assets 73.8 59.2 24.7%
Total expenses 12,647.0 10,014.2 26.3%
Income before income taxes 1,172.7 928.9 26.2%
Income taxes 440.9 317.2 39.0%
Net income $731.8 $611.7 19.6%
Net income per diluted share $1.09 $0.98 11.2%
Diluted shares (in millions) 669.3 621.6 7.7%
Benefit expense as a percentage of
premiums 81.3% 80.9% 40 bp
Selling, general and administrative
expense as a percentage of
total operating revenue 16.0% 16.0% 0 bp
Income before income taxes as a
percentage of total revenues 8.5% 8.5% 0 bp
WellPoint, Inc.
Consolidated Balance Sheets
($ In Millions) March 31, December 31,
2006 2005
(Unaudited)
Assets
Current assets:
Cash and cash equivalents $2,140.0 $2,740.2
Investments available-for-sale, at
fair value 2,095.0 2,182.8
Other invested assets, current 429.0 307.0
Accrued investment income 159.1 156.8
Premiums and self-funded
receivables 2,280.7 2,216.4
Other receivables 1,022.5 831.4
Securities lending collateral 1,191.2 1,389.9
Deferred tax assets, net 505.0 689.0
Other current assets 1,189.3 1,022.7
Total current assets 11,011.8 11,536.2
Long-term investments
available-for-sale, at fair value 15,596.2 14,898.2
Other invested assets, long-term 221.6 207.8
Property and equipment, net 1,047.4 1,078.6
Goodwill 13,465.5 13,469.1
Other intangible assets 9,612.6 9,686.4
Other noncurrent assets 410.6 410.9
Total assets $51,365.7 $51,287.2
Liabilities and shareholders' equity
Liabilities
Current liabilities:
Policy liabilities:
Medical claims payable $5,162.5 $4,853.4
Reserves for future policy benefits 83.9 82.1
Other policyholder liabilities 1,945.2 1,752.3
Total policy liabilities 7,191.6 6,687.8
Unearned income 1,635.3 1,057.1
Accounts payable and accrued expenses 2,459.8 2,860.4
Income taxes payable 984.7 833.4
Security trades pending payable 163.0 181.8
Securities lending payable 1,191.2 1,389.9
Current portion of long-term debt 476.1 481.2
Other current liabilities 1,410.4 1,286.8
Total current liabilities 15,512.1 14,778.4
Long-term debt, less current portion 6,663.9 6,324.7
Reserves for future policy benefits,
noncurrent 686.1 679.9
Deferred income taxes 3,143.9 3,267.1
Other noncurrent liabilities 1,246.8 1,244.0
Total liabilities 27,252.8 26,294.1
Shareholders' equity
Common stock 6.4 6.6
Additional paid-in capital 20,404.7 20,915.4
Retained earnings 3,775.7 4,173.5
Unearned stock compensation -
- (82.1)
Accumulated other comprehensive loss (73.9) (20.3)
Total shareholders' equity 24,112.9 24,993.1
Total liabilities and shareholders'
equity $51,365.7 $51,287.2
WellPoint, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
Three Months Ended March 31
($ In Millions) 2006 2005
Operating activities
Net income $731.8 $611.7
Adjustments to reconcile net income
to net cash provided by operating activities:
Net realized losses on investments 7.1 1.0
Gain on disposal of assets (1.4) (0.7)
Deferred income taxes 101.6 54.5
Amortization, net of accretion 113.5 105.3
Depreciation 34.9 23.1
Stock-based compensation 54.6 15.7
Excess tax benefits from
share-based compensation (36.3) -
-
Changes in operating assets
and liabilities, net of
effect of business combinations:
Receivables, net (236.5) (76.5)
Other invested
assets, current (122.0) -
-
Other assets (164.8) (23.5)
Policy liabilities 520.0 144.2
Unearned income 578.2 40.9
Accounts payable and
accrued expenses (103.2) (113.4)
Other liabilities 116.7 (120.8)
Income taxes 203.4 269.9
Net cash provided by operating activities 1,797.6 931.4
Investing activities
Purchases of investments (5,634.1) (2,094.0)
Proceeds from sales and maturities of
investments 4,882.4 1,389.3
Changes in securities lending collateral 198.7 (177.8)
Purchases of subsidiaries, net of
cash acquired -
- (110.3)
Payment for settlement of cash flow hedge (24.7) -
-
Purchases of property and equipment (36.4) (37.1)
Proceeds from sales of property and
equipment 1.4 1.5
Net cash used in investing activities (612.7) (1,028.4)
Financing activities
Net (repayment of) proceeds from
commercial paper borrowings (606.7) 5.5
Proceeds from long-term borrowings 2,668.9 -
-
Repayment of long-term borrowings (1,703.8) -
-
Changes in securities lending payable (198.7) 177.8
Changes in bank overdrafts (266.2) (220.9)
Repurchase and retirement of common stock (1,912.0) (88.5)
Proceeds from exercise of employee
stock options and employee stock
purchase plan 197.1 256.8
Excess tax benefits from share-based
compensation 36.3 -
-
Net cash (used in) provided by
financing activities (1,785.1) 130.7
Change in cash and cash equivalents (600.2) 33.7
Cash and cash equivalents at
beginning of period 2,740.2 1,457.2
Cash and cash equivalents at end of period $2,140.0 $1,490.9
WellPoint, Inc.
Selected Financial Data - Comparable Basis Analysis
(Unaudited)
($ In Millions) As Reported
Three Months Ended March 31
2006 2005 % Change
Revenues
Premiums $12,578.9 $10,015.9 25.6%
Administrative fees 884.0 660.7 33.8%
Other revenue 151.8 128.8 17.9%
Total operating revenue 13,614.7 10,805.4 26.0%
Expenses
Benefit expense 10,230.8 8,099.1 26.3%
Selling, general and administrative
expense
Selling expense 401.4 359.5 11.7%
General and administrative expense 1,771.2 1,369.6 29.3%
Total selling, general and
administrative expense 2,172.6 1,729.1 25.6%
Cost of drugs 75.8 73.6 3.0%
Benefit expense as a percentage of
premiums 81.3% 80.9% 40 bp
Selling, general and administrative
expense as a percentage of
total operating revenue 16.0% 16.0% 0 bp
($ In Millions) Comparable Basis (1)
Three Months Ended March 31
2005 $ Change % Change
Revenues
Premiums $11,381.4 $1,197.5 10.5%
Administrative fees 820.6 63.4 7.7%
Other revenue 128.7 23.1 17.9%
Total operating revenue 12,330.7 1,284.0 10.4%
Expenses
Benefit expense 9,280.0 950.8 10.2%
Selling, general and administrative
expense
Selling expense 376.7 24.7 6.6%
General and administrative
expense 1,600.9 170.3 10.6%
Total selling, general and
administrative expense 1,977.6 195.0 9.9%
Cost of drugs 73.6 2.2 3.0%
Benefit expense as a percentage of
premiums 81.5% (20)bp
Selling, general and administrative
expense as a percentage of
total operating revenue 16.0% 0 bp
(1) The "Comparable Basis" information is a non-GAAP measure. Refer to
the table entitled, "Consolidated Statements of Income - Comparable Basis
Reconciliation."
WellPoint, Inc.
Reportable Segment Highlights - Comparable Basis Analysis
(Unaudited)
($ In Millions) As Reported
Three Months Ended March 31
2006 2005 % Change
Operating Revenue
Health Care Segment $13,057.9 $10,283.1 27.0%
Specialty Segment 854.2 750.9 13.8%
Other Segment (297.4) (228.6) (30.1%)
Total Operating Revenue 13,614.7 10,805.4 26.0%
Operating Gain (Loss)
Health Care Segment $1,035.9 $856.7 20.9%
Specialty Segment 113.6 94.4 20.3%
Other Segment (14.0) (47.5) 70.5%
Operating Margin (2)
Health Care Segment 7.9% 8.3% (40)bp
Specialty Segment 13.3% 12.6% 70 bp
($ In Millions) Comparable Basis (1)
Three Months Ended March 31
2005 $ Change % Change
Operating Revenue
Health Care Segment $11,766.1 $1,291.8 11.0%
Specialty Segment 759.2 95.0 12.5%
Other Segment (194.6) (102.8) (52.8%)
Total Operating Revenue 12,330.7 1,284.0 10.4%
Operating Gain (Loss)
Health Care Segment $953.7 $82.2 8.6%
Specialty Segment 95.0 18.6 19.6%
Other Segment (49.2) 35.2 71.5%
Operating Margin (2)
Health Care Segment 8.1% (20)bp
Specialty Segment 12.5% 80 bp
(1) The "Comparable Basis" information is a non-GAAP measure. Refer to
the table entitled, "Reportable Segment Highlights - Comparable Basis
Reconciliation."
(2) Operating margin is calculated as operating gain as a percentage of
operating revenue.
WellPoint, Inc.
Reclassified Consolidated Statements of Income - Comparable Basis
Reconciliation
(Unaudited)
Three Months Ended March 31, 2005
($ In Millions) WLP (1) Reclassifications WLP (1) WC (1)
As Reported (2) Reclassified As Reported
Revenues
Premiums $10,158.8 $(142.9) $10,015.9 $1,385.1
Administrative fees 664.2 (3.5) 660.7 141.3
Other revenue 139.2 (10.4) 128.8 (0.1)
Total operating
revenue 10,962.2 (156.8) 10,805.4 1,526.3
Net investment income 138.7 - 138.7 17.8
Net realized gains
(losses) on
investments (1.0) - (1.0) 0.6
Total revenues 11,099.9 (156.8) 10,943.1 1,544.7
Expenses
Benefit expense 8,255.9 (156.8) 8,099.1 1,197.3
Selling, general and
administrative expense
Selling expense 359.5 - 359.5 -
General and
administrative
expense 1,369.6 - 1,369.6 233.1
Total selling,
general and
administrative
expense 1,729.1 - 1,729.1 233.1
Cost of drugs 73.6 - 73.6 -
Interest expense 53.2 - 53.2 -
Amortization of other
intangible assets 59.2 - 59.2 -
Total expenses 10,171.0 (156.8) 10,014.2 1,430.4
Income before
income taxes 928.9 - 928.9 114.3
Income taxes 317.2 - 317.2 43.4
Net income $611.7 $ - $611.7 $70.9
Benefit expense
as a percentage
of premiums 81.3% 80.9% 86.4%
Selling, general and
administrative expense
as a percentage of
total operating
revenue 15.8% 16.0% 15.3%
Three Months Ended March 31, 2005
WellPoint,
($ In Millions) Inc.
Reclassifications WC (1) Comparable
(2) Reclassified Basis (3)
Revenues
Premiums $(19.6) $1,365.5 $11,381.4
Administrative fees 18.6 159.9 820.6
Other revenue - (0.1) 128.7
Total operating revenue (1.0) 1,525.3 12,330.7
Net investment income - 17.8 156.5
Net realized gains (losses) on
investments - 0.6 (0.4)
Total revenues (1.0) 1,543.7 12,486.8
Expenses
Benefit expense (16.4) 1,180.9 9,280.0
Selling, general and
administrative expense
Selling expense 17.2 17.2 376.7
General and administrative
expense (1.8) 231.3 1,600.9
Total selling, general and
administrative expense 15.4 248.5 1,977.6
Cost of drugs - - 73.6
Interest expense - - 53.2
Amortization of other intangible
assets - - 59.2
Total expenses (1.0) 1,429.4 11,443.6
Income before income taxes - 114.3 1,043.2
Income taxes - 43.4 360.6
Net income $ - $70.9 $682.6
Benefit expense as a
percentage of premiums 86.5% 81.5%
Selling, general and administrative
expense as a percentage
of total operating revenue 16.3% 16.0%
(1) WLP = WellPoint, Inc.; WC = WellChoice, Inc.
(2) To reflect the reclassification of certain historical amounts to a
consistent presentation format adopted by the combined organization. In
connection with the acquisition of WellChoice, Inc., the Company adopted a
consistent practice for reporting minimum premium amendments to fully-insured
contracts throughout the combined enterprise.
(3) The "Comparable Basis" information was calculated by adding the
reclassified consolidated statements of income for WellPoint, Inc. and the
former WellChoice, Inc. This "Comparable Basis" information contains no
intercompany eliminations or pro forma adjustments resulting from WellPoint,
Inc.'s acquisition of WellChoice, Inc. "Comparable Basis" information is
presented in order to provide investors with a more meaningful comparison to
the current period, due to the acquisition of WellChoice, Inc. "Comparable
Basis" information is not calculated in accordance with GAAP and is not
intended to represent or be indicative of the results that WellPoint, Inc.
would have reported, had the acquisition been completed as of January 1, 2005.
WellPoint, Inc.
Reclassified Reportable Segment Highlights - Comparable Basis
Reconciliation
(Unaudited)
Three Months Ended March 31, 2005
($ In Millions) WLP (1) WLP (1) WC (1)
As Reclassifications Reclassified As
Reported (2) Reported
Operating Revenue (4)
Health Care $10,476.4 $(193.3) $10,283.1 $ -
Specialty 695.4 55.5 750.9 -
Other (209.6) (19.0) (228.6) -
Commercial Managed Care - - - 1,299.8
Other Insurance Products
and Services - - - 226.5
Total operating
revenue 10,962.2 (156.8) 10,805.4 1,526.3
Operating Gain (Loss) (4)
Health Care 860.6 (3.9) 856.7 -
Specialty 91.7 2.7 94.4 -
Other (48.7) 1.2 (47.5) -
Commercial Managed Care - - - 85.6
Other Insurance
Products and Services - - - 10.3
Three Months Ended March 31, 2005
WellPoint,
($ In Millions) WC (1) Inc.
Reclassifications (2) Reclassified Comparable
Basis (3)
Operating Revenue (4)
Health Care $1,483.0 $1,483.0 $11,766.1
Specialty 8.3 8.3 759.2
Other 34.0 34.0 (194.6)
Commercial Managed Care (1,299.8) - -
Other Insurance Products and
Services (226.5) - -
Total operating revenue (1.0) 1,525.3 12,330.7
Operating Gain (Loss) (4)
Health Care 97.0 97.0 953.7
Specialty 0.6 0.6 95.0
Other (1.7) (1.7) (49.2)
Commercial Managed Care (85.6) - -
Other Insurance Products and
Services (10.3) - -
(1) WLP = WellPoint, Inc.; WC = WellChoice, Inc.
(2) To reflect the reclassification of certain historical amounts to a
consistent presentation format adopted by the combined organization. In
connection with the acquisition of WellChoice, Inc., the Company adopted a
consistent practice for reporting minimum premium amendments to fully-insured
contracts throughout the combined enterprise.
(3) The "Comparable Basis" information was calculated by adding the
reclassified consolidated statements of income for WellPoint, Inc. and the
former WellChoice, Inc. This "Comparable Basis" information contains no
intercompany eliminations or pro forma adjustments resulting from WellPoint,
Inc.'s acquisition of WellChoice, Inc. "Comparable Basis" information is
presented in order to provide investors with a more meaningful comparison to
the current period, due to the acquisition of WellChoice, Inc. "Comparable
Basis" information is not calculated in accordance with GAAP and is not
intended to represent or be indicative of the results that WellPoint, Inc.
would have reported, had the acquisition been completed as of January 1, 2005.
(4) Operating revenue and operating gain are the key measures used by
management to evaluate performance in each segment. Operating gain is defined
as operating revenue less benefit expense, selling expense, general and
administrative expense, and cost of drugs. Operating gain is used to analyze
profit or loss on a segment basis. Consolidated operating gain is a non-GAAP
measure.
WellPoint, Inc.
Days in Claims Payable
(Unaudited)
($ In Millions) December 31, 2005
WLP Comparable
March 31, WLP As Comparable Basis
2006 Reported(1) WC(2) Basis(3) Change
Medical claims
payable $5,162.5 $4,853.4 -
- $4,853.4
Benefit expense $10,230.8 $8,200.3 $1,305.9 $9,506.2
Days 90 92 -
- 92
Days in claims
payable 45.4 54.5 -
- 47.0 (1.6)
(1) On December 28, 2005, WellPoint, Inc. acquired WellChoice, Inc ("WC").
Therefore, the medical claims payable balance as of December 31, 2005,
included WC, however benefit expense for the three months ended December 31,
2005, did not include WC.
(2) Represents WC's benefit expense for the three months ended December
31, 2005.
(3) The "Comparable Basis" benefit expense was calculated by adding WC's
benefit expense for the three months ended December 31, 2005, to WellPoint,
Inc.'s benefit expense for the same period.
WellPoint, Inc.
Operating Cash Flow as a Multiple of Net Income
(Unaudited)
($ In Millions) Three Months Ended March 31, 2006 (1)
April 2006
As Reported CMS Payments Adjusted
Operating cash flow $1,797.6 $447.6 $1,350.0
Net income $731.8 -
- $731.8
Operating cash flow as a
multiple of net income 2.5 -
- 1.8
(1) Operating cash flow for the three months ended March 31, 2006,
included the receipt of $447.6 million in CMS payments that relate to the
second quarter of 2006. Due to the magnitude of these payments, the Company
has presented the "Operating Cash Flow as a Multiple of Net Income" metric on
an adjusted basis (which excludes these payments from first quarter 2006
operating cash flow) in order to facilitate period-to-period analysis.
SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES
LITIGATION REFORM ACT OF 1995
This press release contains certain forward-looking information about
WellPoint, Inc. ("WellPoint") that is intended to be covered by the safe
harbor for "forward-looking statements" provided by the Private Securities
Litigation Reform Act of 1995. Forward-looking statements are statements that
are not historical facts. Words such as "expect(s)", "feel(s)", "believe(s)",
"will", "may", "anticipate(s)" and similar expressions are intended to
identify forward-looking statements. These statements include, but are not
limited to, financial projections and estimates and their underlying
assumptions; statements regarding plans, objectives and expectations with
respect to future operations, products and services; and statements regarding
future performance. Such statements are subject to certain risks and
uncertainties, many of which are difficult to predict and generally beyond the
control of WellPoint, that could cause actual results to differ materially
from those expressed in, or implied or projected by, the forward-looking
information and statements. These risks and uncertainties include: those
discussed and identified in public filings with the U.S. Securities and
Exchange Commission ("SEC") made by WellPoint and WellChoice, Inc.
("WellChoice"); trends in health care costs and utilization rates; our ability
to secure sufficient premium rate increases; competitor pricing below market
trends of increasing costs; increased government regulation of health benefits
and managed care; significant acquisitions or divestitures by major
competitors; introduction and utilization of new prescription drugs and
technology; a downgrade in our financial strength ratings; litigation and
investigations targeted at health benefits companies and our ability to
resolve litigation and investigations within estimates; our ability to
contract with providers consistent with past practice; other potential uses of
cash in the future that present attractive alternatives to share repurchases;
our ability to achieve expected synergies and operating efficiencies in the
WellPoint Health Networks Inc. merger and WellChoice acquisition within the
expected time-frames or at all and to successfully integrate our operations;
such integration may be more difficult, time-consuming or costly than
expected; revenues following the transactions may be lower than expected;
operating costs, customer loss and business disruption, including, without
limitation, difficulties in maintaining relationships with employees,
customers, clients or suppliers, may be greater than expected following the
transactions; our ability to meet expectations regarding repurchases of shares
of our common stock; our ability to meet expectations regarding the accounting
and tax treatments of the transactions and the value of transaction
consideration; future bio-terrorist activity or other potential public health
epidemics; and general economic downturns. Readers are cautioned not to place
undue reliance on these forward-looking statements that speak only as of the
date hereof. WellPoint does not undertake any obligation to republish revised
forward-looking statements to reflect events or circumstances after the date
hereof or to reflect the occurrence of unanticipated events. Readers are also
urged to carefully review and consider the various disclosures in WellPoint's
and WellChoice's various SEC reports, including but not limited to WellPoint's
Annual Report on Form 10-K for the year ended December 31, 2005.
SOURCE WellPoint, Inc.
-0- 04/26/2006
/CONTACT: Investor Relations: Wayne DeVeydt, +1-317-488-6390, Media:
James Kappel, +1-317-488-6400, both of WellPoint, Inc./
CO: WellPoint, Inc.
ST: Indiana
IN: HEA INS
SU: ERN ERP CCA
ML-TM
-- DEW001 --
5827 04/26/2006 06:00 EDT http://www.prnewswire.com